Thursday 23 August 2012

Views of Deflazacort


Welcome To Plenus Pharmaceuticals (P) Ltd
Plenus Pharmaceuticals is built on its meaning of completeness in pharmaceutical field through our quality healthcare service that leads to healthy life everywhere. It is complete healthcare in every aspect where there is no compromise with quality of products, ensuring full satisfaction to concerned entities.

Deflazacort works by acting within cells to prevent the release of certain chemicals that are important in the immune system. These chemicals are normally involved in producing immune and allergic responses, resulting in inflammation. By decreasing the release of these chemicals in a particular area, inflammation is reduced. These include severe allergic reactions, inflammation of the lungs in asthma and inflammation of the joints in arthritis.

Getting the most from your treatment:
- Long courses of deflazacort can make you more likely to catch infections; therefore, if you come into contact with anyone who has, or who thinks they may have, measles, shingles or chickenpox, you must see your doctor as soon as possible.
 - If you need to take deflazacort for more than 3 weeks you will be given a steroid treatment card. This is a blue card with details about your dose and length of treatment. It also has some important information for you about taking steroids.
- Before having any kind of medical treatment or surgery, including dental or emergency treatment or any medical tests, tell the doctor, dentist or surgeon you are taking deflazacort and show them your steroid treatment card.
 - While taking deflazacort do not have any vaccinations without speaking to your doctor first.
 - Keep any regular doctor's appointments so your progress can be monitored.
 - If you buy any medicines, check with a pharmacist that they are safe to take with deflazacort.


Keywords

Contact Us-

Plenus Pharmaceuticals Private Limited
PLENUS BUILDING
SHIV VIHAR, NEAR LAL MANDIR,
ARYA NAGAR JWALAPUR,
HARIDWAR. (U.K.) 249407
Mobile: 09737475726














No comments:

Post a Comment